| Dr Ashley Marie Fowler, PSYD | |
|
1525 Sam Rittenberg Blvd Ste 103, Charleston, SC 29407-4139 | |
| (509) 680-0093 | |
| Not Available |
| Full Name | Dr Ashley Marie Fowler |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical Child & Adolescent |
| Location | 1525 Sam Rittenberg Blvd Ste 103, Charleston, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013506963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC2200X | Psychologist - Clinical Child & Adolescent | PSY1719 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashley Marie Fowler, PSYD 939 Cottingham Dr, Mount Pleasant, SC 29464-3501 Ph: (509) 680-0093 | Dr Ashley Marie Fowler, PSYD 1525 Sam Rittenberg Blvd Ste 103, Charleston, SC 29407-4139 Ph: (509) 680-0093 |
News Archive
Boston University School of Medicine (BUSM) researchers have identified a promising screening tool to detect intimate partner violence (IPV) in females in the VA Boston Healthcare System.
Researchers, doctors and patients tend to agree that during the high-risk period after an attempted suicide, the treatment of choice is close contact, follow-up and personal interaction in order to prevent a tragic repeat. Now, however, new research shows that this strategy does not work. These surprising results from Mental Health Services in the Capital Region of Denmark and the University of Copenhagen have just been published in the British Medical Journal.
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
In a feature analysis, Devex examines the history of PEPFAR, the program's sustainability, its use of public-private partnerships, and the potential impact of the closure earlier this month of the Global Health Initiative (GHI) office.
› Verified 5 days ago
Dr. Anna Birks, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 109 Bee Street, Charleston, SC 29401 Phone: 843-789-7316 | |
Christine Reineke Bachmann, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1 Poston Rd, Suite 145, Charleston, SC 29407 Phone: 843-556-4157 Fax: 843-763-8747 | |
Dr. Janet Rose, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 215 E Bay St, Suite 501, Charleston, SC 29401 Phone: 843-708-4308 Fax: 843-723-8324 | |
Dr. Kathryn Reid, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1016 Telfair Way, Charleston, SC 29412 Phone: 804-338-1820 | |
Mrs. Angela Geddes, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 505 Arlington Dr, Charleston, SC 29414 Phone: 843-606-0136 | |
David Brian Haver Jr., PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |